BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33348308)

  • 1. Berberine in the treatment of ulcerative colitis: A possible pathway through Tuft cells.
    Xiong X; Cheng Z; Wu F; Hu M; Liu Z; Dong R; Chen G
    Biomed Pharmacother; 2021 Feb; 134():111129. PubMed ID: 33348308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of Th17 cell differentiation via sphingosine-1-phosphate receptor 2 by cinnamaldehyde can ameliorate ulcerative colitis.
    Qu SL; Chen L; Wen XS; Zuo JP; Wang XY; Lu ZJ; Yang YF
    Biomed Pharmacother; 2021 Feb; 134():111116. PubMed ID: 33341041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gisekia pharnaceoides Restores Colonic Mucosal Homeostasis by Regulating Antioxidant Enzyme System and Cytokines Signaling in Ulcerative Colitis Mice Model.
    Javaid F; Aslam N; Arshad HM; Awan AM; Majeed W; Jabeen Q
    Endocr Metab Immune Disord Drug Targets; 2022; 22(1):133-142. PubMed ID: 34751126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of phosphodiesterase-4 attenuates murine ulcerative colitis through interference with mucosal immunity.
    Li H; Fan C; Feng C; Wu Y; Lu H; He P; Yang X; Zhu F; Qi Q; Gao Y; Zuo J; Tang W
    Br J Pharmacol; 2019 Jul; 176(13):2209-2226. PubMed ID: 30883697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kuijieling regulates the differentiation of Treg and Th17 cells to ameliorate experimental colitis in rats.
    Long Y; Li S; Qin J; Xie L; Gan L; Jie F; Wu Y; Li Y; Du Q
    Biomed Pharmacother; 2018 Sep; 105():781-788. PubMed ID: 29909346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase I Trial of Berberine in Chinese with Ulcerative Colitis.
    Xu L; Zhang Y; Xue X; Liu J; Li ZS; Yang GY; Song Y; Pan Y; Ma Y; Hu S; Wen A; Jia Y; Rodriguez LM; Tull MB; Benante K; Khan SA; Cao Y; Jovanovic B; Richmond E; Umar A; Bergan R; Wu K
    Cancer Prev Res (Phila); 2020 Jan; 13(1):117-126. PubMed ID: 31619442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of Averrhoa bilimbi L. fruit extract on ulcerative colitis in wistar rats via regulation of inflammatory mediators and cytokines.
    Suluvoy JK; Sakthivel KM; Guruvayoorappan C; Berlin Grace VM
    Biomed Pharmacother; 2017 Jul; 91():1113-1121. PubMed ID: 28531922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response and inflammatory pathway of ulcerative colitis.
    Tatiya-Aphiradee N; Chatuphonprasert W; Jarukamjorn K
    J Basic Clin Physiol Pharmacol; 2018 Dec; 30(1):1-10. PubMed ID: 30063466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unconjugated bilirubin alleviates experimental ulcerative colitis by regulating intestinal barrier function and immune inflammation.
    Zheng JD; He Y; Yu HY; Liu YL; Ge YX; Li XT; Li X; Wang Y; Guo MR; Qu YL; Qin XF; Jiang MS; Wang XH
    World J Gastroenterol; 2019 Apr; 25(15):1865-1878. PubMed ID: 31057300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of berberine hydrochloride on DSS-induced ulcerative colitis in rats.
    Zhu L; Gu P; Shen H
    Int Immunopharmacol; 2019 Mar; 68():242-251. PubMed ID: 30743078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems pharmacology approach reveals protective mechanisms of Jian-Pi Qing-Chang decoction on ulcerative colitis.
    Chen YL; Zheng YY; Dai YC; Zhang YL; Tang ZP
    World J Gastroenterol; 2019 Jun; 25(21):2603-2622. PubMed ID: 31210713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine inhibits dendritic cells differentiation in DSS-induced colitis by promoting Bacteroides fragilis.
    Zheng C; Wang Y; Xu Y; Zhou L; Hassan S; Xu G; Zou X; Zhang M
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108329. PubMed ID: 34749293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory effects of methanol extract of Patrinia scabiosaefolia in mice with ulcerative colitis.
    Cho EJ; Shin JS; Noh YS; Cho YW; Hong SJ; Park JH; Lee JY; Lee JY; Lee KT
    J Ethnopharmacol; 2011 Jul; 136(3):428-35. PubMed ID: 20573566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of the Tec Kinase ITK Drives Resolution of T Cell-Mediated Colitis and Emerges as Potential Therapeutic Option in Ulcerative Colitis.
    Lechner K; Mott S; Al-Saifi R; Knipfer L; Wirtz S; Atreya R; Vieth M; Rath T; Fraass T; Winter Z; August A; Luban J; Zimmermann VS; Weigmann B; Neurath MF
    Gastroenterology; 2021 Oct; 161(4):1270-1287.e19. PubMed ID: 34224738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of pro-inflammatory cytokine release by selective inhibition of inducible nitric oxide synthase in mucosal explants from patients with ulcerative colitis.
    Kankuri E; Hämäläinen M; Hukkanen M; Salmenperä P; Kivilaakso E; Vapaatalo H; Moilanen E
    Scand J Gastroenterol; 2003 Feb; 38(2):186-92. PubMed ID: 12678336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artesunate ameliorates DSS-induced ulcerative colitis by protecting intestinal barrier and inhibiting inflammatory response.
    Yin S; Yang H; Tao Y; Wei S; Li L; Liu M; Li J
    Inflammation; 2020 Apr; 43(2):765-776. PubMed ID: 31897917
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Loganes C; Valencic E; Pin A; Marini E; Martelossi S; Naviglio S; De Leo L; Not T; Monasta L; Tommasini A; Marcuzzi A
    World J Gastroenterol; 2016 Nov; 22(44):9734-9743. PubMed ID: 27956797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an XBP1 agonist, HLJ2, as a potential therapeutic agent for ulcerative colitis.
    Zhang H; Zhang Z; Song G; Tang X; Song H; Deng A; Wang W; Wu L; Qin H
    Eur J Pharm Sci; 2017 Nov; 109():56-64. PubMed ID: 28757346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid receptor modulates dendritic cell function in ulcerative colitis.
    Yang X; Geng J; Meng H
    Histol Histopathol; 2020 Dec; 35(12):1379-1389. PubMed ID: 32706033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway.
    Li C; Ai G; Wang Y; Lu Q; Luo C; Tan L; Lin G; Liu Y; Li Y; Zeng H; Chen J; Lin Z; Xian Y; Huang X; Xie J; Su Z
    Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.